High prevalence of gastroduodenal mucosal injury in patients taking selective serotonin reuptake inhibitors

Digestive Endoscopy

Volumn 22, Issue 1, 2010, Pages 77-

  Yamamoto, Takatsugu ^a   Abe, Koichiro ^a   Hattori, Kengo ^a   Ishii, Taro ^a   Kuyama, Yasushi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE MALEATE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

CANCER SCREENING; CONTROLLED STUDY; DUODENUM INJURY; DUODENUM MUCOSA; GASTROINTESTINAL ENDOSCOPY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PREVALENCE; REFLUX ESOPHAGITIS;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 74049134798     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/j.1443-1661.2009.00923.x     Document Type: Letter

References (2)

1. Loke YK, Trivedi AN, Singh S et al. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment. Pharmacol. Ther. 2008 27 : 31 40.
2. Opatrny L, Delaney JA, Suissa S et al. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br. J. Clin. Pharmacol. 2008 66 : 76 81.